Thiopurines: Use them or lose them? International survey on current and future use of thiopurines in inflammatory bowel disease.
Fiche publication
Date publication
juin 2021
Journal
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Auteurs
Membres identifiés du Cancéropôle Est :
Pr PEYRIN-BIROULET Laurent
Tous les auteurs :
Sousa P, Ministro P, Armuzzi A, Dignass A, Høivik ML, Barreiro-de Acosta M, Vavricka S, Saad-Hossne R, Gustavo Kotze P, Peyrin-Biroulet L, Magro F
Lien Pubmed
Résumé
The role of thiopurines in therapeutic algorithms of Crohn's disease (CD) and Ulcerative colitis (UC) is being questioned. This work aimed to investigate current practice and future perspectives of Inflammatory Bowel Disease (IBD) physicians regarding the efficacy, safety, and role of precision medicine with thiopurines in IBD.
Mots clés
Crohn's disease, Inflammatory bowel disease, Precision medicine, Thiopurines, Ulcerative colitis
Référence
Dig Liver Dis. 2021 Jun 26;: